Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol

Alcohol and Alcoholism

Volumn 41, Issue 1, 2006, Pages 24-32

  Nowak, Karen L ^a,b   Vinod, Yaragudri K ^a,b   Hungund, Basalingappa L ^a,b,c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c Colombia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALCOHOL; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; RIMONABANT;

ALCOHOL TOLERANCE; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; GENE TARGETING; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; SLEEP TIME;

ALCOHOLISM; ANIMALS; BODY TEMPERATURE; CYCLOHEXANOLS; DRUG TOLERANCE; ETHANOL; HYPOTHERMIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1;

ANIMALIA;

EID: 30744434372     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agh217     Document Type: Article

References (57)

1. Arnone, M., Maruani, J., Chaperon, F. et al. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716A, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132, 104-106.
2. 35S]guanosine triphosphate gammas binding in the brain of C57/BL6 and DBA/2 mice. Journal of Neuroscience Research 64, 429-436.
3. Basavarajappa, B. S. and Hungund, B. L. (1999a) Chronic ethanol increases the cannabinoid reczeptor agonist, anandamide and its precursor N-arachidonyl phosphatidyl ethanolamine in SK-N-SH cells. Journal of Neurochemistry 72, 522-528.
4. 35S] GTPγ S binding in synaptic plasma membranes from chronic ethanol exposed mouse. Brain Research 815, 89-97.
5. Basavarajappa, B. S., Cooper, T. B. and Hungund, B. L. (1998) Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Research 793, 212-218.
6. Basavarajappa, B. S., Saito, M., Cooper, T. B. et al. (2000) Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochemical Biophysical Acta 1535, 78-86.
7. Biscaia, M., Marin, S., Fernandez, B. et al. (2003) Chronic treatment with CP-55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology 170, 301-308.
8. Blum, K., Hudson, K. C., Friedman, R. N. et al. (1975) Tetrahydrocannabinol: Inhibition of alcohol-induced withdrawal symptoms in mice. In Drug Addiction, Vol. 3, Neurobiology and Influences on Behaviour, Singh, J. and Lal, H. eds, pp 39-53. Stratton Intercon Med Book Corp., New York.
9. Boehm, S.L., Peden, L., Chang, R. et al. (2003) Deletion of the fynkinase gene alters behavioural sensitivity to ethanol. Alcoholism: Clinical and Experimental Research 27, 1033-1040.
10. Bouaboula, M., Perrachon, S., Milligan, L. et al. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Journal of Biological Chemistry 272, 22330-22339.
11. Breivogel, C.S., Griffin, G., Di Marzo, V. et al. (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology 60, 155-163.
12. Colombo, G., Agabio, R., Fa, M. et al. (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol 33, 126-130.
13. Colombo, G., Serra, S., Brunetti, G. et al. (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 159, 181-187.
14. Compton, D. R., Aceto, M. D., Lowe, J. et al. (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of (9-tetrahydrocannabinol-induced responses and apparent agonist activity. Journal of Pharmacology and Experimental Therapeutics 277, 586-594.
15. Cowen, M. S., Schroff, K. C., Gass, P. et al. (2003) Neurobehavioural effects of alcohol in AMPA receptor subunit (GluR1) deficient mice. Neuropsychopharmacology 45, 325-333.
16. Darmani, N. A. and Pandya, D. K. (2000) Involvement of other neurotransmitters in behaviours induced by the cannabinoid CB1 receptor antagonist SR 141716A in naïve mice. Journal Neural Transmission 107, 931-945.
17. 9-tetrahydrocannabinol in mice. European Journal of Pharmacology 431, 201-207.
18. Davies, J. A. and Graham, J. D. (1980) The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice. Psychopharmacology 69, 299-305.
19. De Vry, J. and Jentzsch, K. R. (2004) Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm. Behavioural Pharmacology 15, 13-20.
20. Freedland, C. S., Sharpe, A. L., Samson, H. H. et al. (2001) Effects of SR141716A on ethanol and sucrose self-administration. Alcoholism: Clinical and Experimental Research 25, 277-282.
21. Gallate, J. E. and McGregor, I. S. (1999) The motivation for beer in rats: Effects of ritanserin, naloxone and SR141716. Psychopharmacology 142, 302-308.
22. Gallate, J. E., Saharov, T., Mallet, P. E. et al. (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology 370, 233-240.
23. Genn, R. F., Tucci, S., Marco, E. M. et al. (2004) Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP-55,940 in the social interaction test. Pharmacology, Biochemistry and Behaviour 77, 567-573.
24. Goldstein, D. B. and Pal, N. (1971) Alcohol dependence produced in mice by inhalation of ethanol: Grading the withdrawal reaction. Science 172, 288-290.
25. Hajos, N., Ledent, C. and Freund, T. F. (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106, 1-4.
26. Hungund, B. L. and Basavarajappa, B. S. (2000) Distinct differences in the cannabinoid receptor binding in the brain of C57/BL6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. Journal of Neuroscience Research 60, 122-128.
27. Hungund, B. L., Basavarajappa, B. S., Vadasz, C. et al. (2002) Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcoholism: Clinical and Experimental Research 26, 565-574.
28. Hungund, B. L., Szakall, I., Adam, A. et al. (2003) Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. Journal of Neurochemistry 84, 698-704.
29. 9-THC and the CB1 receptor antagonist SR-141716 in rats: Open-field revisited. Pharmacology, Biochemistry and Behaviour 73, 911-919.
30. Kliethermes, C. L., Cronise, K. and Crabbe, J. C. (2004) Anxiety-like behaviour in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation. Alcoholism: Clinical and Experimental Research 28, 1012-1019.
31. Lallemand, F., Soubrie, P. H. and De Witte, P. H. (2001) Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcoholism: Clinical and Experimental Research 25, 1317-1323.
32. Landsman, R. S., Burkey, T. H., Consroe, P. et al. (1997) SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. European Journal of Pharmacology 334, R1-R2.
33. Littleton, J. and Little, H. (1994) Current concepts of ethanol dependence. Addiction 89, 1397-1412.
34. Lundquist, F. (1959) The determination of ethyl alcohol in blood and tissue. Methods in Biochemical Analalysis 7, 217-251.
35. MacLennan, S. J., Reynen, P. H., Kwan, J. et al. (1998) Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. British Journal of Pharmacology 124, 619-622.
36. Malone, D. T. and Taylor, D. A. (1998) Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. British Journal of Pharmacology 124, 1419-1424.
37. Moldrich, G. and Wenger, T. (2000) Localization of the CB1 cannabinoid receptor in the rat brain; An immunohistochemical study. Peptides 21, 1735-1742.
38. Naassila, M., Pierrefiche, O., Ledent, C. et al. (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46, 243-253.
39. Nava, F., Carta, G. and Gessa, G. L. (2000) Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats. Pharmacology Biochemistry and Behaviour 66, 183-187.
40. Norwood, C. S., Cornish, J. L., Mallet, P. E. et al. (2003) Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioural sensitization and alters morphine self-administration in Lewis rats. European Journal of Pharmacology 465, 105-114.
41. Oviedo, A., Glowa, J. and Herkenham, M. (1993) Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study. Brain Research 616, 293-302.
42. Poncelet, M., Maruani, J., Calassi, R. and Soubrie, P. (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neuroscience Letters 343, 216-218.
43. Rawls, S. M., Cowan, A., Tallarida, R. J. et al. (2002) N-methyl-D-aspartate antagonists and WIN 55212-2
44. Rinaldi-Carmona, M., Barth, F., Heaulme, M. et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters 350, 240-244.
45. Rodriguez de Fonseca, F., Roberts, A. J., Bilbao, A. et al. (1999) Cannabinoid receptor antagonist SR141716A decreases operant ethanol self-administration in rats exposed to ethanol-vapor chambers. Zhongguo Yao Li Xue Bao 20, 1109-1114.
46. Romero, J., de Miguel, R., Ramos, J. A. et al. (1998) The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sciences 62, 351-363.
47. Rubino, T., Patrini, M., Massi, P. et al. (1997) Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Molecular Brain Research 44, 191-197.
48. Rubino, T., Vigano, D., Massi, P. et al. (2000) Changes in the cannabinoid receptor binding, G-protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. Journal of Neurochemistry 75, 2080-2086.
49. Serra, S., Brunetti, G., Pani, M. et al. (2002) Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. European Journal of Pharmacology 443, 95-97.
50. Siemens, A. J. and Doyle, O. L. (1979) Cross-tolerance between delta 9-tetrahydrocannabinol and ethanol: The role of drug disposition. Pharmacology Biochemistry and Behaviour 10, 49-55.
51. Sim-Selley, L. J. and Martin, B. R. (2002) Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl) methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl] (1naphthalenyl) methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. Journal of Pharmacology and Experimental Therapeutics 303, 36-44.
52. Sim-Selley, L. J., Brunk, L. K. and Selley, D. E. (2001) Inhibitory effects of SR141716A on G-protein activation in rat brain. European Journal of Pharmacology 414, 135-143.
53. Sprague, G.L. and Craigmill, A.L. (1976) Ethanol and delta-9-tetrahydrocannabinol: Mechanism for cross-tolerance in mice. Pharmacology Biochemistry and Behaviour 5, 409-415.
54. Sprague, G. L. and Craigmill, A. L. (1978) Effects of two cannabinoids upon abstinence signs in ethanol-dependent mice. Pharmacology Biochemistry and Behaviour 9, 11-15.
55. Syapin, P. J., Gee, K. W. and Alkana, R. L. (1987) Ro15-4513 differentially affects ethanol-induced hypnosis and hypothermia. Brain Research Bulletin 19, 603-605.
56. Wang, L., Li, J., Harvey-White, J. et al. (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proceedings of National Academy of Sciences of the United States of America 100, 1393-1398.
57. Wiley, J. L. and Martin, B. R. (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. European Journal of Pharmacology 471, 185-193.